Press release
Surging Incidence Of Renal Cancer Fuels Growth In The Kidney Cancer Drugs Market: A Key Driver Powering Kidney Cancer Drugs Market Growth In 2025
Kidney Cancer Drugs
What Is the Current Kidney Cancer Drugs Market Size and Its Estimated Growth Rate?
The market size for drugs related to kidney cancer has significantly expanded in the past few years. It is projected to rise from $8.2 billion in 2024 to $8.63 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.1%. Factors such as a surge in healthcare spending, rapid increase in the elderly population, amplified pharmaceutical R&D expenses, and advancements in the discovery of cancer drugs, have contributed to the growth observed in the previous period.
In the coming years, the kidney cancer drugs market is predicted to experience consistent growth, expected to reach $10.48 billion in 2029, with a compound annual growth rate (CAGR) of 5.0%. This projected development within the forecast period can be linked to several factors like growing elderly population, an increase in healthcare spending, more partnerships and acquisitions aimed at drug development, and the promising potential of developing economies. Looking at the forecast period, some dominating trends include the utilization of 3D technology in drug production and model creation, investment in biomarkers, initiation or adoption of novel treatment advancements, improving therapies through personalized medicine, investing in AI solutions, and forming collaborations with other businesses or governmental agencies in order to expedite the creation of new drugs.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2591
How Are Emerging Segments Shaping the Kidney Cancer Drugs Market Landscape?
The kidney cancer drugs market covered in this report is segmented -
1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)
2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Other Products
3) By End Users: Hospitals, Clinics, Research Center, Other End-Users
Subsegments:
1) By Renal Cell Carcinoma (RCC): Targeted Therapies, Immune Checkpoint Inhibitors, Cytokine Therapies
2) By Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC): Chemotherapy Agents, Immunotherapy Agents, Antibody-Drug Conjugates (ADCs)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2591&type=smp
Which Growth Factors Are Influencing Kidney Cancer Drugs Market Expansion?
The escalating prevalence of renal cancer is a key factor propelling the kidney cancer drugs market. People's lifestyle modifications, intake of tobacco, and poor diet are among the elements contributing to the development of renal cancer cells. As an example, the American Cancer Society, a healthcare organization based in the US that is committed to eradicating cancer, declared in January 2022 that 79,000 new kidney cancer cases (50,290 men and 28,710 women) would be detected and 13,920 individuals (8,960 men and 4,960 women) were expected to succumb to the disease. Most people are diagnosed between the ages of 65 and 74, with a median diagnosis age of 64. Kidney cancer is relatively uncommon in people under 45, thus fuelling the expansion of the kidney cancer drugs market.
Who Are the Dominant Players Across Different Kidney Cancer Drugs Market Segments?
Major companies operating in the kidney cancer drugs market include Pfizer Inc., Novartis AG, ExelixisInc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Bayer AG, Merck & Co., Inc., EUSA Pharma Inc., UroGen Pharma Ltd., Natco Pharma, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co., Ltd, Daiichi Pharmaceutical and Sankyo, AstraZeneca plc, GlaxoSmithKline plc, Amgen Inc ., Biocon Ltd, Rani Therapeutics, Eli Lilly and Company, Abbvie, Johnson & Johnson, Sanofi, Biogen Inc, AVEO Oncology, Teva Pharmaceutical Industries Ltd., Kitov Pharma Limited, CureTech Ltd., Neopharma
What Kidney Cancer Drugs Market Trends Are Gaining Traction Across Different Segments?
Leading businesses in the kidney cancer drugs market are concentrating on technologies like biosimilar development to bolster treatment choices, enhance patient accessibility to cost-effective therapies, and speed up innovation in cancer care. Biosimilar development is the process of producing biological drugs that closely resemble an already authorized reference product, guaranteeing equivalent efficacy, safety, and quality. For example, in November 2022, US-based Amneal Pharmaceuticals Inc. launched RELEUKO (filgrastim-ayow), a biosimilar to Neupogen (filgrastim) developed by the same company. This product is aimed to treat neutropenia, especially in patients undergoing chemotherapy.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Kidney Cancer Drugs Market in the Coming Years?
North America was the largest region in the kidney cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the global kidney cancer drugs market share during the forecast period. The regions covered in the kidney cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Kidney Cancer Drugs Market?
2. What is the CAGR expected in the Kidney Cancer Drugs Market?
3. What Are the Key Innovations Transforming the Kidney Cancer Drugs Industry?
4. Which Region Is Leading the Kidney Cancer Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surging Incidence Of Renal Cancer Fuels Growth In The Kidney Cancer Drugs Market: A Key Driver Powering Kidney Cancer Drugs Market Growth In 2025 here
News-ID: 4005524 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Kidney
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and…
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key…
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook:
The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring…
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025
Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
